Regulation of complement-mediated swine endothelial cell lysis by herpes simplex virus glycoprotein, gC1

Journal of Biochemistry

Volumn 131, Issue 5, 2002, Pages 745-749

  Matsunami, Katsuyoshi ^a,b   Miyagawa, Shuji ^a   Fukuta, Daisuke ^c   Shirakura, Ryota ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Animal Engineering Research Institute   (Japan)

^c Nipro Corporation   (Japan)

Author keywords

Complement regulatory protein; HSV gC1; Swine endothelial cell; Xenograft

Indexed keywords

VIRUS GLYCOPROTEIN; COMPLEMENT COMPONENT C3B; GLYCOPROTEIN GC, HERPES SIMPLEX VIRUS TYPE 1; LACTATE DEHYDROGENASE; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; CHO CELL; COMPLEMENT DEPENDENT CYTOTOXICITY; CYTOLYSIS; ENDOTHELIUM CELL; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS 1; IMMUNOREGULATION; NONHUMAN; PROTEIN EXPRESSION; SWINE; VIRUS GENOME; XENOTRANSPLANTATION; ANIMAL; BIOSYNTHESIS; BLOOD; CRICETULUS; CYTOLOGY; CYTOTOXICITY TEST; DOWN REGULATION; ENDOTHELIUM; FLOW CYTOMETRY; GENETICS; HAMSTER; HUMAN; IMMUNOLOGY; WESTERN BLOTTING; XENOGRAFT;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS; DNA VIRUSES; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS; SUS SCROFA;

ANIMALS; BLOTTING, WESTERN; CHO CELLS; COMPLEMENT C3B; CRICETINAE; CRICETULUS; CYTOTOXICITY TESTS, IMMUNOLOGIC; DOWN-REGULATION; ENDOTHELIUM; FLOW CYTOMETRY; HUMANS; L-LACTATE DEHYDROGENASE; SWINE; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; VIRAL ENVELOPE PROTEINS;

EID: 0036561414     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jbchem.a003160     Document Type: Article

References (25)

1. The Mechanism of discordant xenograft rejection
2. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury
3. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection
4. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs. A potential approach for preventing xenograft rejection
5. Transgenic pigs expressing human decay-accelerating factor regulated by porcine MCP gene promoter
6. New directions for organ transplantation
7. Attempts to prepare suitable complement regulatory molecules for clinical xenotransplantation
8. One step ahead of the game: Viral immunomodulatory molecules
9. In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC
10. Regulation of complement-mediated swine endothelial cell lysis by a surface-bound form of human C4b binding protein
11. Function of human factor H and I on xeno-surface
12. A surface-bound form of human C1 esterase inhibitor improves xenograft rejection
13. Effects of transfected complement regulatory proteins. MCP, DAF, MCP/DAF hybrid, on complement-mediated swine endothelial cell lysis
14. Efficient selection for high-expression transfectants with a novel eukaryotic vector
15. Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins
16. Structure/function studies of human decay-accelerating factor
17. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
18. Roles of histamine, complement and xanthine oxidase in thermal injury of skin
19. Orthotopic heart transplantation in a transgenic pig-to-primate model
20. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors
21. The immune response to herpes simplex virus: Comparison of the specificity and relative titers of serum antibodies directed against viral polypeptides following primary herpes simplex virus type 1 infections
22. Binding of complement component C3b to glycoprotein C is modulated by sialic acid on herpes simplex virus type 1-infected cells
23. Calnexin associates with the precursors of glycoproteins B, C, and D of herpes simplex virus type 1
24. Vaccinia virus complement control protein is capable of protecting xeno-endothelial cells from antibody binding and killing by human complement and cytotoxic cells
25. In vitro prevention of cell-mediated xeno-graft rejection via the Fas/FasL-pathway in CrmA-transducted porcine kidney cells